Eli Lilly's Zepbound is the first and only approved dual GLP-1/GIP agonist, and Lilly is also working on its own triple ...

Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose weight more effectively and stay on track with its flagship medication, Wegovy ...

Oracle shares surged last week after the company reported better-than-expected earnings and projected robust growth in its cloud infrastructure revenue. CEO Safra Catz attributed the strong ...